Xiamenximier Electronic Commerce Co Ltd
General
Total Cases1
Active Cases1
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
---|---|---|
02/19/25 | SUMMONS Issued as to Xiamenximier Electronic Commerce Co., Ltd., d/b/a Cenny. (KLC) (Entered: 02/19/2025) | |
02/19/25 | Case Assigned to District Judge Rodney Gilstrap. (NKL) (Entered: 02/19/2025) | |
02/19/25 | In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form [Consent to Proceed Before Magistrate Judge] is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge. (NKL) (Entered: 02/19/2025) | |
02/18/25 | NOTICE of Attorney Appearance by Joseph Michael Mercadante on behalf of Aardvark Medical Inc. (Mercadante, Joseph) (Entered: 02/18/2025) | |
02/18/25 | NOTICE of Attorney Appearance by Evan Langdon on behalf of Aardvark Medical Inc. (Langdon, Evan) (Entered: 02/18/2025) | |
02/18/25 | NOTICE of Attorney Appearance by Alfred Ross Fabricant on behalf of Aardvark Medical Inc. (Fabricant, Alfred) (Entered: 02/18/2025) | |
02/18/25 | Fed. R. Civ. P. 7.1(a)(1) Disclosure Statement filed by Aardvark Medical Inc. (Fabricant, Alfred) (Entered: 02/18/2025) | |
02/18/25 | Notice of Filing of Patent/Trademark Form (AO 120). AO 120 emailed to the Director of the U.S. Patent and Trademark Office. (Fabricant, Alfred) (Entered: 02/18/2025) | |
02/18/25 | COMPLAINT FOR PATENT INFRINGEMENT against Xiamenximier Electronic Commerce Co., Ltd., d/b/a Cenny ( Filing fee $ 405 receipt number ATXEDC-10683405.), filed by Aardvark Medical Inc.. (Attachments: # [1] Civil Cover Sheet)(Fabricant, Alfred) (Entered: 02/18/2025) |